Symbols

AURA

Aura Biosciences·NASDAQ

--(--)

AURA Profile

Aura Biosciences, Inc.

A biotechnology company that develops novel targeted therapies for cancer

Industry

Biological Technology

Established Date

Listing Date

10/29/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

113

Fiscal Year Ends

12-31

Website

www.aurabiosciences.com

Security Type

Common stock

Office address

80 Guest Street Boston MA 02135

Business

Introduction

Aura Biosciences, Inc., was incorporated in January 2009 under the laws of the State of Delaware. The company is a clinical-stage biotechnology company that develops precision therapies for the treatment of solid tumors designed to protect organ function. The company's lead product candidate, bel-sar, is in late-stage clinical development for the treatment of patients with early-stage choroidal melanoma, and is also in clinical development for other ocular tumor indications and bladder cancer.